Management options for vulvar carcinoma in a low resource setting.

Authors:
Dr Ahizechukwu C Eke, MD, MPH, FWACS
Dr Ahizechukwu C Eke, MD, MPH, FWACS
Division of Maternal Fetal Medicine & Clinical Pharmacology, Johns Hopkins University School of Medicine, 600 N Wolfe Street
Maternal Fetal Medicine
Baltimore, Maryland | United States

World J Surg Oncol 2010 Nov 1;8:94. Epub 2010 Nov 1.

Department of Obstetrics and Gynecology, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Anambra State, Nigeria.

Background: Vulvar carcinoma is a rare tumor of the female genital tract. In Nigeria, very few studies have looked at the management options for vulvar carcinoma. The objective of this study was therefore, to describe the management options available and the challenges in treating this malignancy in Nigeria.

Methods: A descriptive study of all vulvar cancer cases managed at the Nnamdi Azikiwe University Teaching Hospital, Nnewi over a 12 year period (1998-2009). The theatre, ward register, histo-pathologic records and case notes of all women who had surgery for vulvar carcinomas were retrieved and socio-demographic characteristics, clinical presentation, type of surgery, histologic type and complications of treatment were retrieved and analyzed.

Results: There were 867 gynecological malignancies and vulval carcinoma accounted for 11 cases, giving a prevalence of 1.27%. The ages ranged from 54 to 79 years with a mean of 61.2 years. Parity was 2-14, with a mean of 6.7 ± 2.33. Most of the patients were of low socio-economic class. All the 11 patients had surgery as 1st line treatment. Radical vulvectomy was done for 6 cases since they presented in the advanced stage. The complications of surgery included hemorrhage (18.2%), chronic lymphedema, wound infection and anesthetic complications. There were no hospital mortalities. Late presentation, with stage III (45.4%) was the commonest stage at presentation while the majority of the vulvar carcinomas (72.7%) were of epithelial origin. Squamous cell carcinoma predominated (63.6%).

Conclusion: Carcinoma of the vulva is a rare gynecological malignancy in Nigeria. Surgery and radiotherapy remains the mainstay of this disease in Nigeria and can be highly successful if patients present early.

Download full-text PDF

Source
http://dx.doi.org/10.1186/1477-7819-8-94DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987879PMC
November 2010
10 Reads
4 Citations
1.200 Impact Factor

Publication Analysis

Top Keywords

vulvar carcinoma
12
management options
12
options vulvar
8
vulvar carcinomas
8
carcinoma
6
vulvar
6
surgery
5
867 gynecological
4
gynecological malignancies
4
majority vulvar
4
treatment retrieved
4
complications treatment
4
malignancies vulval
4
carcinomas 727%
4
retrieved analyzedresults
4
analyzedresults 867
4
carcinoma accounted
4
stage presentation
4
prevalence 127%
4
commonest stage
4

References

(Supplied by CrossRef)

A Mohammed et al.
Annals of African Medicine 2006

N Siddiqui et al.
Curr Obstet Gynaecol 2002

RCOG Publications et al.
2006

AH De-Cherney et al.
2007

D Luesley et al.
1999

ND Briggs et al.
Int J Gynecol Obstet 1990

K Nkyekyer et al.
East Afr Med J 2000

J Kasule et al.
East Afr Med J 1989

DM Hay et al.
J Obstet Gynaecol Brit Commwlth 1969

S Perecolli et al.
Int J Gynaecol Obstet 2009

Similar Publications